Saved source record
Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans.
This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.
Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.
Study metadata
- Study type
- Original study
- Study category (metadata hint)
- Human
- Published
- 2025-11-22
- Authors
- Galbiati F, Plessow F, Plummer L, Campbell MB, Nazarloo S, Carter CS, Davis JM, Miller KK
- Journal or registry
- Not reported
- Registry study design
- Not reported
- Registry enrollment
- Not reported
- Funding agencies
- FDA HHS; NIMH NIH HHS; NIDDK NIH HHS; NICHD NIH HHS; Food and Drug Administration; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases
- Identifiers
- DOI: 10.1111/jne.70114 · PMID: 41273106 · PMCID: PMC12797869
- First found
- Sep 25, 2026
- Last found
- Sep 25, 2026
Original sources
Browse saved studies · Search live sources